Cargando…
Intra-amniotic Sildenafil Treatment Modulates Vascular Smooth Muscle Cell Phenotype in the Nitrofen Model of Congenital Diaphragmatic Hernia
The etiology of pulmonary vascular abnormalities in CDH is incompletely understood. Studies have demonstrated improvement in pulmonary vasculature with prenatal therapy in animal models. We hypothesize that prenatal sildenafil may attenuate defective pulmonary vascular development via modulation of...
Autores principales: | Okolo, Frances C., Zhang, Guangfeng, Rhodes, Julie, Potoka, Douglas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281652/ https://www.ncbi.nlm.nih.gov/pubmed/30518769 http://dx.doi.org/10.1038/s41598-018-34948-w |
Ejemplares similares
-
Intra-amniotic sildenafil treatment improves lung blood flow and pulmonary hypertension in congenital diaphragmatic hernia rats
por: Yoshida, Shiho, et al.
Publicado: (2023) -
VEGF receptor expression decreases during lung
development in congenital diaphragmatic hernia induced by
nitrofen
por: Sbragia, L., et al.
Publicado: (2014) -
Prenatal Molecular Hydrogen Administration Ameliorates Several Findings in Nitrofen-Induced Congenital Diaphragmatic Hernia
por: Miura, Mayo, et al.
Publicado: (2021) -
ANG-1 TIE-2 and BMPR Signalling Defects Are Not Seen in the Nitrofen Model of Pulmonary Hypertension and Congenital Diaphragmatic Hernia
por: Corbett, Harriet Jane, et al.
Publicado: (2012) -
Role of catalytic iron and oxidative stress in nitrofen-induced congenital diaphragmatic hernia and its amelioration by Saireito (TJ-114)
por: Hirako, Shima, et al.
Publicado: (2017)